Company Overview
Management
Board of Directors
Investors
Protein Optimization
ReCode™ Technology
Site Matters
Intellectual Property
Current Opportunities
Benefits
Corporate Fact Sheet
Pipeline
Protein Optimization
AMBRX NEWS
Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
Ambrx Announces Drug Discovery Alliance with Eli Lilly and Company
© Copyright 2005-2009 Ambrx, Inc. All rights reserved.
